DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Omaxe Limited — Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

NSE 4 hrs ago·18 Aug 2026, 12:48 pm

Omaxe

Omaxe Limited has informed the stock exchanges regarding a significant administrative update concerning its regulatory approvals. The company has confirmed that a key regulatory approval has been granted, which is a procedural milestone for its ongoing projects and business operations.

For investors, this news is generally viewed positively as it removes a potential hurdle for the company's expansion plans. Securing this approval suggests that the project is on track and may lead to smoother execution in the future. It signals a step forward in the company's ability to develop its real estate assets.

Moving forward, investors should monitor the specific details of the approval to understand its scope and timeline. Keeping an eye on the company's future project announcements will also be crucial to gauge the impact of this regulatory clarity on its growth trajectory.